Literature DB >> 11371700

Indinavir and systemic hypertension.

A M Cattelan1, M Trevenzoli, L Sasset, L Rinaldi, V Balasso, P Cadrobbi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11371700     DOI： 10.1097/00002030-200104130-00021

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  19 in total

Review 1.  Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

Authors:  Carl J Fichtenbaum; John G Gerber
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Coronary heart disease in HIV-infected patients.

Authors:  Marshall J Glesby
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

Review 3.  Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.

Authors:  Bente Magny Bergersen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.

Authors:  Stine Johnsen; Sara E Dolan; Kathleen V Fitch; Jenna R Kanter; Linda C Hemphill; Jean M Connelly; Robert S Lees; Hang Lee; Steve Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-09-26       Impact factor: 5.958

Review 5.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Renal Dysfunction in HIV-1-infected Patients.

Authors:  Jeffrey B. Kopp
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

7.  Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice.

Authors:  Trinity Vera; Joey P Granger; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-01       Impact factor: 3.619

8.  Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.

Authors:  B M Bergersen; L Sandvik; O Dunlop; K Birkeland; J N Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-11       Impact factor: 3.267

9.  Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.

Authors:  Paula Freitas; Davide Carvalho; Ana Cristina Santos; António José Madureira; Sandra Xerinda; Esteban Martinez; Jorge Pereira; António Sarmento; José Luís Medina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

10.  Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals.

Authors:  Ingjerd W Manner; Marius Trøseid; Olav Oektedalen; Morten Baekken; Ingrid Os
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-26       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.